You just read:

Novartis Pharmaceuticals Canada Inc. receives Health Canada approval for ILARIS* in active Systemic Juvenile Idiopathic Arthritis, a serious form of rare childhood arthritis

News provided by

Novartis Pharmaceuticals Canada Inc.

Dec 17, 2013, 07:17 ET